Diabetic nephropathy is the leading cause of kidney disease in patients starting renal replacement therapy and affects ~40% of type 1 and type 2 diabetic patients. It increases the risk of death ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney ...

Table 1. Diabetic Nephropathy Stages: Cutoff Values of Urine Albumin for Diagnosis and Main Clinical Characteristics Stages Albuminuria cutoff values (ref. 14) Clinical characteristics (ref. no.) ...

Smoking increases the likelihood of developing numerous morbidities; however, it remains unclear how this behavior may impact ...

R3R-01 is under development for the treatment of Alport syndrome, diabetic kidney disease and focal segmental glomerulosclerosis. It is administered through oral route.

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD) - the leading cause of kidney failure in the world - that could see patients treated with new gene and drug ...

New potential therapeutic targets have been identified for diabetic kidney disease (DKD)—the leading cause of kidney failure in the world—that could see patients treated with new gene and drug ...

Atrasentan hydrochloride is under clinical development by Novartis and currently in Phase II for Diabetic Nephropathy.

The International Bancshares Corporation Foundation has donated $400,000 to the Joe R. and Teresa Lozano Long School of ...

More than two billion people worldwide live with overweight or obesity, conditions closely linked to an array of health ...